Molecular Templates Inc (MTEM)

[Gold prospector]

Have you seen this?

Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) saw a large growth in short interest in the month of January. As of January 15th, there was short interest totalling 2,169,360 shares, a growth of 40.8% from the December 31st total of 1,540,359 shares, MarketBeat.com reports. Based on an average daily volume of 1,173,211 shares, the short-interest ratio is presently 1.8 days. Currently, 3.4% of the shares of the company are short sold.
Several equities research analysts have weighed in on the company. Cowen and Company downgraded Threshold Pharmaceuticals from an “outperform” rating to a “market perform” rating in a research report on Monday, December 7th. Stifel Nicolaus downgraded Threshold Pharmaceuticals from a “buy” rating to a “hold” rating in a research report on Monday, December 7th. Piper Jaffray downgraded Threshold Pharmaceuticals from an “overweight” rating to a “neutral” rating in a research report on Monday, December 7th. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and set a $14.00 price target on shares of Threshold Pharmaceuticals in a research report on Monday, October 5th. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $13.50.
Shares of Threshold Pharmaceuticals (NASDAQ:THLD) opened at 0.32 on Friday. The stock’s 50 day moving average is $0.43 and its 200 day moving average is $3.18. The stock’s market capitalization is $22.87 million. Threshold Pharmaceuticals has a 1-year low of $0.29 and a 1-year high of $5.28.

http://www.emqtv.com/short-interest-in-threshold-pharmaceuticals-inc-thld-increases-by-40-8/178707/